EXPLEOSOL
EXPLEO SOLUTIONS LIMITEDInformation Technology
LTP
836.75
CHG · %
+15.7 (+1.91%)
VOL · TODAY
34.53K
PREV CLOSE
821.05
Today's range813 · 839.75
836.75
52-week range640 · 1,182.9
836.75
Loading candles…
Expleo Solutions Ltd is a subsidiary of the French-based Expleo Group that provides software validation and verification services primarily to the banking, financial services, and insurance (BFSI) industry on a worldwide scale. The company also offers digital transformation, quality assurance, and software testing services across BFSI as well as aerospace, automotive, and transportation industries. It leverages a global delivery model to offer localized expertise combined with offshore scalability. While details concerning its incorporation year, headquarters, founders, key management, and public listings are not specified, the company’s focus spans multiple business segments related to software quality and transformation services across several industries worldwide.
EXPLEOSOL is not part of any active scan today.
This page is a live market overview for EXPLEO SOLUTIONS LIMITED (EXPLEOSOL) on the NSE. As a listed security, EXPLEO SOLUTIONS LIMITED is tracked in the Information Technology segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for EXPLEOSOL before placing trades on tick2trade.
As of the latest feed, EXPLEOSOL last traded at ₹836.75 on NSE, up ₹15.7 (1.91%) from the previous close of ₹821.05. Today's session range is ₹813 – ₹839.75, against a 52-week band of ₹640 – ₹1,182.9. Traded volume today stands at 34.53K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for EXPLEOSOL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether EXPLEOSOL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for EXPLEO SOLUTIONS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in EXPLEOSOL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated EXPLEOSOL option chain page linked from this overview.